Apotex Recalls Meloxicam 15mg Due to Oversized Tablet
Apotex Corp. recalls one lot of 15 mg Meloxicam tablets due to a slightly oversized tablet. Check your bottle's lot number and expiration date.
Recall notice
Tablet Thickness: Recall was initiated due to the presence of one slightly oversized tablet in a bottle of the identified lot.
Contact the company
What happened, in plain English
Apotex Corp. has recalled one specific lot of Meloxicam Tablets, USP, 15 mg because it contained one slightly oversized tablet. The recall affects 1,749 bottles distributed nationwide. The record does not specify any remedy or instructions for consumers regarding what to do with the product. Read more at govinfonow.com/recall/48936-apotex-corp-recalls-meloxicam-tablets-usp-15-mg-rx-only.
Source Summary by GovInfoNow · govinfonow.com/recall/48936-apotex-corp-recalls-meloxicam-tablets-usp-15-mg-rx-only · Updated October 13, 2026 · FDA enforcement record: FDA #D-1443-2012
Cite this page
“Apotex Recalls Meloxicam 15mg Due to Oversized Tablet.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/48936-apotex-corp-recalls-meloxicam-tablets-usp-15-mg-rx-only. Based on FDA recall #D-1443-2012 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1443-2012%22&limit=1).
Why it’s dangerous
The hazard is described solely as the presence of one slightly oversized tablet in a bottle. The record does not explain how this physical defect poses a risk or causes injury.
Who’s affected
Consumers who purchased Meloxicam Tablets, USP, 15 mg manufactured by Strides Acrolab Ltd. and distributed by Apotex Corp. nationwide before April 5, 2012.
How to tell if you have this one
Look for Meloxicam Tablets, USP, 15 mg, Rx Only, in bottles of 100 tablets. Check for NDC 60505-3579-1, Lot number 7212558, and an expiration date of 12/12.
- Brand
Apotex- Category
Drug
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 17 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Other Apotex recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1443-2012 (April 5, 2012) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1443-2012 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.